Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Issues FY 2025 Earnings Guidance

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 4.800-5.330 for the period. The company issued revenue guidance of $48.3 billion-$50.2 billion.

Bayer Aktiengesellschaft Price Performance

OTCMKTS:BAYRY opened at $6.60 on Thursday. Bayer Aktiengesellschaft has a one year low of $4.79 and a one year high of $8.58. The stock has a market cap of $25.92 billion, a PE ratio of -25.37 and a beta of 1.02. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.81 and a current ratio of 1.32. The stock has a 50 day moving average price of $5.49 and a 200 day moving average price of $6.28.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.